Autopsy report · NCT06965881
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
Cause of deathSlow enrollment
“Study was terminated due to the lack of operational capabilities of the sites to segregate participants as needed.”
Life of this trial
- Ran for about 2 months before it stopped.
- 30 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- GRIN Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Tuberous Sclerosis Complex (TSC); Focal Cortical Dysplasia; Other Neurological Disorders
- Interventions
- Radiprodil with Carbamazepine; Radiprodil with Itraconazole
- Participants
- 30
- Sites
- 2
- Countries
- Australia
Trials that died the same way
- Starting the Conversation
“The study was terminated due to a small number of study participants.” - Vaginal Estradiol Use in Pessary Care
“There is a lack of potential study participants at our study site that would meet inclusion criteria, therefore, the study is not feasible and is being terminated.” - To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
“the study was early terminated due to lack of recruitment.” - The Role of Splinting in Fingertip Injuries
“Very few subjects were enrolled. Therefore, the study was terminated.” - Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis
“the study was terminated due to participant drop out”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.